Welcome to LookChem.com Sign In|Join Free
  • or
N-(2-furylmethyl)-3,4-dimethoxybenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

187988-72-3

Post Buying Request

187988-72-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

187988-72-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 187988-72-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,7,9,8 and 8 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 187988-72:
(8*1)+(7*8)+(6*7)+(5*9)+(4*8)+(3*8)+(2*7)+(1*2)=223
223 % 10 = 3
So 187988-72-3 is a valid CAS Registry Number.

187988-72-3Relevant academic research and scientific papers

Synthesis, biological evaluation and molecular docking studies of novel trimethoxy-ring derivatives as BRD4 inhibitors

Yang, Yan,Yao, Zhiyi

, p. 1319 - 1328 (2018/11/01)

Background: Bromodomain-containing protein 4 (BRD4) inhibitors synthesized with trimethoxy-ring refer to a new series of small molecular inhibitors. Currently, BRD4 offers the potential for research as a cancer therapeutic target. Based on previous studies, 17 trimethoxy-ring derivatives were designed as novel BRD4 inhibitors. Methods: All these new compounds were synthesized via the amide reaction. Their structures were identified by 1H NRM,13C NRM spectra and HRMS. In vitro antitumor activities of the new compounds were evaluated by MTT. Molecular docking studies were conducted to explain the binding interactions of these compounds with BRD4 protein. Results: A series of novel trimethoxy-ring derivatives were synthesized as BRD4 inhibitors and screened by testing their inhibition against HCT116, MCF-7, K562 and KMS-1 cell lines. Most of the newly synthesized compounds exhibited moderate-to-good inhibitory activity against HCT116, MCF-7, and K562 cell lines, whereas some showed inhibitory activity against the KMS-1 cell line. Conclusion: Compound 3g demonstrated the most potent anti-tumor activity against breast (MCF-7), leukemia (K562), multiple myeloma (KMS-1), and colon cancer (HCT116) cell lines.

BRD4 small-molecule inhibitor with antitumor activity as well as synthetic method and application thereof

-

Paragraph 0063; 0064; 0065, (2018/04/03)

The invention belongs to the technical field of pharmaceutical chemistry and particularly relates to a BRD4 small-molecule inhibitor with antitumor activity as well as a synthetic method and application thereof. The structural formula of the BRD4 small-mo

Ion-exchange resins for solution phase parallel synthesis of chemical libraries

Gayo, Leah M.,Suto, Mark J.

, p. 513 - 516 (2007/10/03)

Described are various techniques that employ ion-exchange resins for the solution-phase synthesis of chemical libraries. We have found these resins to be useful as reagents and/or scavengers in a variety of reactions. Nine basic ion-exchange resins were e

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 187988-72-3